Cheng Tan
Nantong University
5 Papers
Cheng Tan is an academic researcher from Nantong University. The author has contributed to research in topics: Chemistry & Cancer research. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Potential biomarkers for esophageal cancer
TL;DR: The potential biomarkers of esophageal cancer in three aspects were reviewed: Immunohistochemical markers, blood-based markers, miRNA markers and Gene expression profiling, which provided promising therapeutic targets for the diagnosis, treatment, and prognosis of esophileal cancer.
Esophageal cancer stem cells and implications for future therapeutics.
TL;DR: Targeting CSCs of esophageal cancer can be a logical strategy to treat EC, as these cells are responsible for carcinoma recurrence and chemoradiation resistance.
Oroxylin a could be a Promising Radiosensitizer for Esophageal Squamous Cell Carcinoma by Inducing G2/M Arrest and Activating Apoptosis.
TL;DR: Oroxylin A could be a promising radiosensitizer for esophageal squamous cell carcinoma by inducing G2/M phase blocking and activating cell apoptosis and the apoptosis rates were remarkably dose-dependent higher in combination groups than in either Oroxyl in A or radiation alone group.
20
Xiao Chai Hu Tang alleviates the pancreatic tumorigenesis via improving the mtDNA N6-Methyladenine modification mediated mitochondrial dysfunction in Syrian hamster model.
Jun Cai,Wenyuan Shen,Guixian Zhang,Xi Li,Hongsheng Shen,Wen-Chiuan Li,Cheng Tan,Ting Zhang,Mengrou Shi,Zi-Ping Yang,Yuankai Li,Hongbin Liu,Xiumei Zhao +12 more
TL;DR: In this paper , Xiao Chai Hu Tang (XCHT) has a good therapeutic effect on pancreatic cancer patients with advanced stage, the effect and mechanism of XCHT remains unclear in pancreatic tumorigenesis.
3
Synthesis and biological evaluation of (4-hydroxy-2-(substitued sulfonamido)pyrimidine-5-carbonyl)glycines as oral erythropoietin secretagogues.
Shuang Zhi,Jun Cai,Hong Wang,Cheng Tan,Zi-Bo Yang,Lin-Lin Dai,Ting Zhang,Hui Wang,Dongdong Li +8 more
TL;DR: In this article , the authors described the identification of (4-hydroxy-2-(substitued sulfonamido)pyrimidine-5-carbonyl) glycine-based oral EPO secretagogues.
3